Related Experiment Videos
[A follow-up study on rapid cycling affective disorders]
Hua Xi Yi Ke Da Xue Xue Bao = Journal of West China University of Medical Sciences = Huaxi Yike Daxue Xuebao
|September 1, 1989
Summary
Rapid cycling affective disorders (RCAD) patients showed varied relapse rates. Treatment responses differed between depressive and manic relapses, suggesting biological heterogeneity in RCAD.
Area of Science:
- Psychiatry
- Neuroscience
- Pharmacology
Context:
- Manic-depressive illness, also known as bipolar disorder, is a mood disorder characterized by shifts in mood, energy, and activity levels.
- Rapid cycling affective disorders (RCAD) are a subtype of bipolar disorder defined by a specific frequency of mood episodes.
- Long-term follow-up studies are crucial for understanding the course and treatment outcomes of RCAD.
Purpose:
- To investigate the clinical course and treatment response of patients diagnosed with rapid cycling affective disorders (RCAD).
- To determine relapse rates and identify predictors of relapse in a cohort of RCAD patients.
- To explore the potential biological heterogeneity of RCAD based on differential treatment responses.
Summary:
- A cohort of 18 patients meeting the definition for RCAD were followed for 1.5-4.5 years post-discharge.
- Eight patients relapsed into manic-depressive episodes, while 10 remained relapse-free; only one case represented a relapse of RCAD.
- Depressive relapses responded to lithium or antidepressant discontinuation, whereas manic relapses indicated a need for carbamazepine, suggesting distinct underlying mechanisms.
Impact:
- The findings suggest that RCAD may not be a monolithic entity but rather presents with biological heterogeneity.
- Differential treatment responses highlight the importance of personalized medicine approaches in managing RCAD.
- This study contributes to a better understanding of the long-term prognosis and pharmacological management of rapid cycling bipolar disorder.